Spruce Biosciences, Inc. (SPRB) Financials
SPRB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 103.9 million | 27.4 million |
2023-09-30 | 113.0 million | 27.6 million |
2023-06-30 | 126.0 million | 29.4 million |
2023-03-31 | 139.1 million | 31.1 million |
SPRB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -11.2 million | 1.2 million |
2023-09-30 | -12.3 million | 1.1 million |
2023-06-30 | 2.0 million | 1.2 million |
2023-03-31 | -11.8 million | 1.1 million |
SPRB Net Income
No data available :(
SPRB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 96.3 million | - | 1.3 million |
2023-09-30 | 108.0 million | - | 1.3 million |
2023-06-30 | 120.5 million | 2.5 million | 1.1 million |
2023-03-31 | 118.6 million | 2.9 million | 1.2 million |
SPRB Shares Outstanding
SPRB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 11.1 million | 3.0 million | -16000 |
2023-09-30 | 7000 | 13.5 million | 3.2 million | - |
2023-06-30 | - | 13.1 million | 3.0 million | - |
2023-03-31 | - | 11.7 million | 3.5 million | - |
SPRB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 2.9 million | 16000 |
2023-09-30 | 3.1 million | 17000 |
2023-06-30 | 2.2 million | 74000 |
2023-03-31 | 2.0 million | 77000 |
SPRB
Price: $0.70
52 week price:
Earnings Per Share: -1.24 USD
P/E Ratio: -3.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 65629
Market Capitalization: 33.9 million